- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Myelodysplastic Syndrome in France
Total 3638 results
-
Janssen Research & Development, LLCargenxWithdrawnMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicUnited Kingdom, Switzerland, Italy, Germany, France, Spain, Australia, Turkey, Brazil, Russian Federation, Saudi Arabia
-
Institut de Recherches Internationales ServierRecruitingMyelodysplastic Syndromes | Relapsed or Refractory Acute Myeloid Leukemia (AML) | Untreated AML | Other IDH1-mutated Positive Hematologic MalignanciesUnited States, France
-
Molecular Partners AGRecruitingLeukemia | Acute | Relapsed | MyeloidNetherlands, France, Lithuania, Switzerland
-
Janssen Research & Development, LLCActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited Kingdom, France, Korea, Republic of, Spain
-
National Cancer Institute (NCI)Active, not recruitingAnemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | de Novo Myelodysplastic SyndromeUnited States
-
Roswell Park Cancer InstituteNational Heart, Lung, and Blood Institute (NHLBI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Myelodysplastic-Myeloproliferative DiseasesUnited States
-
Syros PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States, France
-
Groupe Francophone des MyelodysplasiesCelgene CorporationTerminatedMyelodysplastic Syndromes | Leukemia, Myelocytic, AcuteFrance
-
Groupe Francophone des MyelodysplasiesCelgene CorporationUnknownAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic SyndromeFrance
-
European Organisation for Research and Treatment...CompletedMyelodysplastic Syndromes | Leukemia | Fungal InfectionBelgium, Netherlands, Germany, France, Czechia, Slovakia
-
Groupe Francophone des MyelodysplasiesAstex Pharmaceuticals, Inc.Completed
-
CelgeneTerminatedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, France, Canada, Norway, Spain, United Kingdom
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
Onconova Therapeutics, Inc.The Leukemia and Lymphoma SocietyCompletedMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | MDS | RAEBUnited States, Belgium, Germany, Spain, France, Italy
-
Millennium Pharmaceuticals, Inc.CompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, ChronicUnited States, Israel, Spain, France, Ireland, Canada, Germany, Czechia, Italy, Netherlands, Belgium, Bulgaria
-
Institut Paoli-CalmettesUnknownLeukemia, Myeloid, Acute | Leukemia, Lymphoblastic, AcuteFrance
-
Assistance Publique - Hôpitaux de ParisGustave Roussy, Cancer Campus, Grand ParisNot yet recruitingMyelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | Old Age | Severe/Moderate CoronavirusFrance
-
European Organisation for Research and Treatment...UnknownMyelodysplastic Syndromes | LeukemiaSwitzerland, Netherlands, France, Belgium, Germany, Sweden, Croatia, Czech Republic, Italy
-
Curis, Inc.RecruitingMyelodysplastic Syndrome | Acute Myelogenous LeukemiaGermany, United States, Spain, Israel, Czechia, Poland, France, Italy
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States, Australia, Canada
-
Bristol-Myers SquibbActive, not recruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, France, Australia, Canada, Italy, Norway, Spain, Sweden, United Kingdom
-
St. Jude Children's Research HospitalActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Institut Paoli-CalmettesCompletedAcute Myeloid Leukemia | Chronic Myeloid Leukemia | Myelodysplastic SyndromeFrance
-
Onconova Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States, France
-
University Hospital, Clermont-FerrandMinistry of Health, France; French Society of HematologyRecruitingLymphoma, Non-Hodgkin | Myelodysplastic Syndromes | Hodgkin Lymphoma | Chronic Lymphocytic Leukemia | Myeloma | Acute Leukemia in Remission | Myeloproliferative SyndromeFrance
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan
-
Agios Pharmaceuticals, Inc.CompletedMyelodysplastic Syndrome | Hematologic Malignancies | Acute Myeloid Leukemia (AML)United States, France
-
SanofiRecruitingMyelodysplastic Syndromes | Acute Lymphocytic Leukaemia | Acute Myeloid Leukaemia Refractory | Blastic Plasmacytoid Dendritic Cell NeoplasiaNetherlands, France, United States, Australia, China
-
Centre Leon BerardRecruitingMyelodysplastic Syndromes | Severe Combined Immunodeficiency | Acute Leukemia | Haematological Malignancy | Hemoglobinopathy in Children | Bone Marrow AplasiaFrance
-
Centre Leon BerardWithdrawnMyelodysplastic Syndromes | Severe Combined Immunodeficiency | Acute Leukemia | Haematological Malignancy | Hemoglobinopathy in Children | Bone Marrow AplasiaFrance
-
University Hospital, BordeauxMinistry for Health and Solidarity, FranceRecruitingThrombocytopenia | Immune Thrombocytopenia | MyelodysplasiaFrance
-
Assistance Publique - Hôpitaux de ParisNovartisCompletedSickle Cell Disease | Thalassemia | MyelodysplasiaFrance
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative NeoplasmsUnited States, Canada, Puerto Rico, Australia, Netherlands, New Zealand, Switzerland
-
Institut de Recherches Internationales ServierActive, not recruitingLeukemia, Myeloid, Acute | Untreated AML | Newly Diagnosed Acute Myeloid Leukemia (AML) | AML Arising From Myelodysplastic Syndrome (MDS)Spain, United States, France, Korea, Republic of, Taiwan, Australia, Canada, Germany, China, Italy, Austria, Czechia, Poland, Japan, United Kingdom, Russian Federation, Netherlands, Brazil, Israel, Mexico
-
FibroGenAstraZeneca; Astellas Pharma IncTerminatedPrimary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)United States, Australia, Belgium, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, France, Turkey, Canada, Denmark, India, Poland
-
Novartis PharmaceuticalsActive, not recruitingMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicChina, Czechia, Japan, Saudi Arabia, Taiwan, Turkey, Germany, Spain, Netherlands, Italy, Singapore, Australia, Austria, France, United Kingdom, Korea, Republic of, Thailand, Israel, Belgium, Canada, Switzerland, Lithuania, Russian Federation and more
-
National Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Acute Myeloid Leukemia Post Cytotoxic TherapyUnited States
-
University Hospital, BordeauxTerminatedLow Anterior Resection Syndrome (LARS>20) | Refractory Medical Treatment After Rectal ResectionFrance
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaBelgium, Hungary, Spain, Germany, Canada, Switzerland, Thailand, Korea, Republic of, United Kingdom, Italy, Austria, Sweden, France, United States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States, Canada
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLeukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Myelodysplastic SyndromeAustralia, United States, Canada, Spain, Belgium, France, Czechia, Italy, Korea, Republic of, Israel, Brazil, China, Germany, Turkey, Japan, Greece, Poland, United Kingdom, Russian Federation, Mexico
-
PfizerCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic SyndromeSpain, Canada, Austria, Czechia, France, Hungary, Italy, Japan, Mexico, Poland, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | LeukemiaUnited States, Canada, Australia
-
CelgeneRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Primary MyelofibrosisUnited States, Puerto Rico
-
GlaxoSmithKlineCompletedMyelodysplastic SyndromePuerto Rico, United States, Taiwan, Germany, Denmark, Hong Kong, Korea, Republic of, France, United Kingdom, Italy, Brazil
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Australia, Canada
-
Incyte CorporationActive, not recruitingMyelodysplastic Syndromes | Multiple Myeloma | AnemiaUnited States, France, Italy
-
CelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteCanada, Spain, United Kingdom, United States, France, Austria, Germany, Italy, Netherlands, Belgium, Portugal, Poland
-
Assistance Publique - Hôpitaux de ParisImagine Institute; Axonal-Biostatem; CERBA laboratory; SATT; SNC Graft Versus Host...RecruitingAcute Lymphoblastic Leukemia | Acute Myeloid Leukemia in Remission | Lymphoma in Remission | Non-progressive Myeloproliferative Syndrome | Myelodysplasia With Stable Blasts is Cell Number and < 10% of Blastocysts | Acute Leukemia Biphenotypic in RemissionFrance, Germany, Belgium
-
Forma Therapeutics, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States, Spain, Korea, Republic of, Australia, Canada, Germany, France, United Kingdom, Italy